{
    "organizations": [],
    "uuid": "254766dfede8edb9ac769bb3e96f251e95132e61",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-active-biotech-says-rights-issue-o/brief-active-biotech-says-rights-issue-oversubscribed-idUSASO0003B9",
    "ord_in_thread": 0,
    "title": "BRIEF-Active Biotech says rights issue oversubscribed",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Active Biotech AB:\n* PRESS RELEASE - REG-ACTIVE BIOTECHâ€™S RIGHTS ISSUE OVER SUBSCRIBED\n* SAYS WILL THEREBY RAISE APPROXIMATELY SEK 48 MILLION BEFORE DEDUCTION OF ISSUE COSTS Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ",
    "published": "2018-04-16T18:43:00.000+03:00",
    "crawled": "2018-04-17T12:18:33.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "active",
        "biotech",
        "ab",
        "press",
        "release",
        "biotech",
        "right",
        "issue",
        "subscribed",
        "say",
        "thereby",
        "raise",
        "approximately",
        "sek",
        "million",
        "deduction",
        "issue",
        "cost",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "stockholm",
        "newsroom"
    ]
}